TAME', MARIAROSA
 Distribuzione geografica
Continente #
NA - Nord America 856
EU - Europa 468
AS - Asia 209
AF - Africa 34
SA - Sud America 1
Totale 1.568
Nazione #
US - Stati Uniti d'America 856
GB - Regno Unito 155
CN - Cina 79
SG - Singapore 79
SE - Svezia 75
DE - Germania 54
IT - Italia 54
IN - India 29
IE - Irlanda 25
UA - Ucraina 24
FR - Francia 22
RU - Federazione Russa 18
EE - Estonia 13
JO - Giordania 13
TG - Togo 11
CH - Svizzera 9
CI - Costa d'Avorio 9
ZA - Sudafrica 9
BG - Bulgaria 7
BE - Belgio 4
NG - Nigeria 4
IR - Iran 3
ES - Italia 2
HR - Croazia 2
MM - Myanmar 2
PL - Polonia 2
BR - Brasile 1
EG - Egitto 1
FI - Finlandia 1
IL - Israele 1
JP - Giappone 1
NL - Olanda 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.568
Città #
Southend 143
Fairfield 131
Chandler 80
Singapore 73
Ashburn 64
Wilmington 60
Woodbridge 50
Houston 44
Cambridge 43
Ann Arbor 42
Seattle 41
Princeton 30
Santa Clara 30
Boardman 29
Dublin 25
Nanjing 18
Westminster 14
Amman 13
Padova 13
Lomé 11
Abidjan 9
Bologna 9
San Diego 9
Berlin 8
Bern 8
Dearborn 8
Jacksonville 7
Saint Petersburg 7
Sofia 7
Jinan 6
Beijing 5
Bremen 5
Guangzhou 5
New York 5
Abeokuta 4
Brussels 4
Jiaxing 4
Los Angeles 4
Milan 4
Nanchang 4
Shenyang 4
Turin 4
Cagliari 3
Des Moines 3
Florence 3
Medford 3
Redwood City 3
Rome 3
Aachen 2
Changsha 2
Haikou 2
Norwalk 2
Patheingyi 2
Providence 2
Redmond 2
Shanghai 2
Tianjin 2
Amsterdam 1
Andover 1
Ardabil 1
Argelato 1
Augusta 1
Bangkok 1
Buffalo 1
Cairo 1
Channahon 1
Chengdu 1
Edinburgh 1
Foshan 1
Fuzhou 1
Hebei 1
Helsinki 1
Kiev 1
Kilburn 1
Kumar 1
Kunming 1
Lanzhou 1
Leawood 1
London 1
Madrid 1
Medicina 1
Minneapolis 1
Monmouth Junction 1
Muizenberg 1
New Kensington 1
Ningbo 1
Olalla 1
Paris 1
Phoenix 1
Plauen 1
Prescot 1
Quanzhou 1
Sacramento 1
Saint Paul 1
Shenzhen 1
Suzhou 1
São Paulo 1
Tokyo 1
Ulan-ude 1
Walnut 1
Totale 1.163
Nome #
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 149
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 137
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 131
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 129
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 125
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 123
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 114
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent. 106
Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. 102
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. 100
Sirolimus in liver transplant recipients: a large single-center experience. 100
Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C. 98
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 97
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort 83
Totale 1.594
Categoria #
all - tutte 3.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 51 46 61 55 53 22 12 27
2020/2021133 37 21 3 2 2 7 3 10 18 8 4 18
2021/2022291 15 6 19 17 23 18 7 16 11 19 100 40
2022/2023324 31 40 23 42 16 24 6 13 65 25 20 19
2023/202483 2 9 1 6 7 12 3 14 16 6 5 2
2024/2025177 19 61 25 20 52 0 0 0 0 0 0 0
Totale 1.594